BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8047089)

  • 1. Therapy for beta-thalassemia--a paradigm for the treatment of genetic disorders.
    Dover GJ; Valle D
    N Engl J Med; 1994 Sep; 331(9):609-10. PubMed ID: 8047089
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalassaemia and other haemoglobinopathies in general practice.
    Webster BH; Lammi AT
    Aust Fam Physician; 1994 Aug; 23(8):1485-90. PubMed ID: 7980148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous chelation therapy during transplantation for thalassemia.
    Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G
    Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
    Brittenham GM; Griffith PM; Nienhuis AW; McLaren CE; Young NS; Tucker EE; Allen CJ; Farrell DE; Harris JW
    N Engl J Med; 1994 Sep; 331(9):567-73. PubMed ID: 8047080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 7. Common queries in thalassemia care.
    Panigrahi I; Marwaha RK
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeuetic management of patients with thalassemia major].
    Thuret I
    Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic iron concentration and total body iron stores in thalassemia major.
    Kami M; Hamaki T; Kishi Y
    N Engl J Med; 2000 Nov; 343(22):1657. PubMed ID: 11184989
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of Cooley's anemia.
    Nathan DG
    Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P; Forte L; Sorrentino F; Palombi M; Papa G; Marciani MG
    Bone Marrow Transplant; 1993; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract]   [Full Text] [Related]  

  • 13. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Andreani M; Agostinelli F; Albertini F; Clift RA
    N Engl J Med; 1993 Sep; 329(12):840-4. PubMed ID: 8355742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of thalassemia major (Cooley's anemia).
    Piomelli S; Loew T
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):557-69. PubMed ID: 1864823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
    De Gobbi M; Pasquero P; Brunello F; Paccotti P; Mazza U; Camaschella C
    Haematologica; 2000 Aug; 85(8):865-7. PubMed ID: 10942934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary embolism and intravenous high-dose desferrioxamine.
    Cianciulli P
    Haematologica; 1992; 77(4):368-9. PubMed ID: 1427452
    [No Abstract]   [Full Text] [Related]  

  • 19. Current trends in management of the beta thalassemias.
    Shah D; Choudhury P; Dubey AP
    Indian Pediatr; 1999 Dec; 36(12):1229-42. PubMed ID: 10745364
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 3 hemochromatosis and beta-thalassemia trait.
    Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
    Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.